Glaxosmithkline Share Price | |
---|---|
Price | 1,660.40 |
Bid | 1,660.40 |
Ask | 1,660.80 |
Change | -0.40 (-0.02%) |
Volume | 603,621 |
Open | 1,662.00 |
High | 1,664.40 |
Low | 1,655.60 |
Prev. Close | 1,660.80 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.06b |
Market Capitalisation | £67.38b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 2,781 |
---|---|
Vol. Sold | 275,968 |
Sold Value | £4.58m |
Vol. Bought | 253,215 |
Bought Value | £4.21m |
PE Ratio | 13.65461 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.343% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
19-Mar-24 | 11:42:42 | 1,660.80 | 2 | Buy* | 1,660.40 | 1,660.80 | 33.22 | O Ordinary Trade was executed as an SI |
19-Mar-24 | 11:42:35 | 1,660.40 | 572 | Sell* | 1,660.40 | 1,660.60 | 9,497 | A Automatic Execution |
19-Mar-24 | 11:42:21 | 1,660.40 | 58 | Sell* | 1,660.40 | 1,660.80 | 963.03 | A Automatic Execution |
19-Mar-24 | 11:42:21 | 1,660.40 | 26 | Sell* | 1,660.40 | 1,660.80 | 431.70 | A Automatic Execution |
19-Mar-24 | 11:42:18 | 1,660.40 | 10 | Sell* | 1,660.40 | 1,660.60 | 166.04 | A Automatic Execution |
19-Mar-24 | 11:42:18 | 1,660.60 | 638 | Sell* | 1,660.60 | 1,660.80 | 10.59k | A Automatic Execution |
19-Mar-24 | 11:42:18 | 1,660.80 | 84 | Buy* | 1,660.60 | 1,660.80 | 1,395 | A Automatic Execution |
19-Mar-24 | 11:42:18 | 1,660.60 | 538 | Sell* | 1,660.60 | 1,660.80 | 8,934 | A Automatic Execution |
19-Mar-24 | 11:42:18 | 1,660.60 | 94 | Sell* | 1,660.60 | 1,660.80 | 1,561 | A Automatic Execution |
19-Mar-24 | 11:42:18 | 1,660.60 | 73 | Sell* | 1,660.60 | 1,660.80 | 1,212 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
26-Feb-24 | 22-Feb-24 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 21.08 | USD | 140 | 464,040 |
26-Feb-24 | 22-Feb-24 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 22.00 | USD | 5,547 | 464,040 |
19-Feb-24 | 16-Feb-24 | Transfer From | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 0.00 | 297,429 | 349,880 | |
19-Feb-24 | 16-Feb-24 | Sell | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,657.97 | GBX | 139,792 | 349,880 |
15-Feb-24 | 12-Feb-24 | Transfer From | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 0.00 | 52,435 | 52,451 |
At GSK, we unite science, technology and talent to get ahead of disease together